Cargando…
Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II)
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent disorder, seen in 20–30% of young adult prisoners. Pharmacoepidemiological studies, a small randomised controlled trial and open trial data of methylphenidate suggest clinically significant reductions in ADHD symptoms,...
Autores principales: | Asherson, Philip, Johansson, Lena, Holland, Rachel, Fahy, Tom, Forester, Andrew, Howitt, Sheila, Lawrie, Stephen, Strang, John, Young, Susan, Landau, Sabine, Thomson, Lindsay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889577/ https://www.ncbi.nlm.nih.gov/pubmed/31791384 http://dx.doi.org/10.1186/s13063-019-3705-9 |
Ejemplares similares
-
Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate
por: Ginsberg, Ylva, et al.
Publicado: (2012) -
The effect of methylphenidate-OROS(®) on the narrative ability of children with attention-deficit hyperactivity disorder
por: Rausch, Tessa L., et al.
Publicado: (2017) -
Social adjustment and family function after drug switch from IR-methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
por: Chou, Wen-Jiun, et al.
Publicado: (2018) -
Bella ciao chansons du peuple en Italie.
Publicado: (1987) -
Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
por: Buitelaar, Jan K, et al.
Publicado: (2009)